Elanco (Thailand) Ltd. is a subsidiary of Elanco Animal Health Incorporated, a global leader in animal health and pharmaceuticals. With a strong presence in Bangkok, Thailand, Elanco focuses on providing innovative animal health solutions to enhance the well-being of companion animals and livestock while supporting sustainable food production.
Core Business and Product Offerings
Elanco specializes in veterinary pharmaceuticals, vaccines, and feed additives, catering to both companion animals and farm animals. The company's product portfolio is divided into two main categories:
1. Companion Animal Health
- Vaccines – Immunization solutions for disease prevention in pets
- Parasiticides – Treatment and prevention of fleas, ticks, and intestinal parasites
- Therapeutics – Medicines for pain management, dermatological conditions, and chronic illnesses in pets
2. Farm Animal Health
- Vaccines – Disease prevention solutions for poultry, swine, cattle, and aquaculture
- Antibiotics – Responsible use of antimicrobial products to manage bacterial infections
- Feed Additives – Nutritional supplements to enhance growth, immunity, and feed efficiency
Market Position and Global Reach
Elanco (Thailand) Ltd. plays a vital role in Asia-Pacific's animal health market, supplying veterinary pharmaceuticals and nutritional solutions to farmers, veterinarians, and pet owners.
Key Market Insights
- Regional Focus: Thailand and the Asia-Pacific region
- Industry Segments: Poultry, swine, dairy, beef cattle, aquaculture, and companion animals
- Distribution Network: Veterinary clinics, agricultural cooperatives, animal feed manufacturers, and pharmaceutical distributors
Market Leadership
- Operating in over 90 countries worldwide
- Thailand contributes significantly to Elanco’s regional market share in Asia-Pacific
- Strong partnerships with veterinarians, livestock producers, and pet care professionals
Innovation and Research Leadership
Elanco invests heavily in research and development (R&D) to drive innovation in animal health. The company focuses on disease prevention, antimicrobial resistance management, and sustainable livestock production.
Key R&D Focus Areas
- Next-Generation Vaccines – Developing preventive solutions to combat emerging diseases
- Antibiotic Stewardship – Ensuring responsible antibiotic use in food-producing animals
- Nutritional Innovations – Advancing feed additive technologies for improved animal growth and welfare
Sustainability and Animal Welfare Commitment
Elanco is committed to sustainable animal health solutions, ensuring a balance between productivity, environmental responsibility, and animal welfare.
- Reducing Antibiotic Use – Promoting alternative health solutions to minimize reliance on antibiotics
- Supporting Sustainable Farming – Developing feed additives that reduce environmental impact
- Improving Pet Health – Advancing longevity and well-being solutions for companion animals
Global Sustainability Initiatives
- Healthy Purpose™ Initiative – A corporate sustainability framework focusing on food security, animal welfare, and responsible antibiotic use
- Net-Zero Commitment – Aiming for carbon neutrality in manufacturing and supply chains
- Elanco Foundation – Supporting global food security projects and pet adoption programs
Regulatory Compliance and Quality Standards
Elanco (Thailand) Ltd. adheres to international animal health regulations, ensuring product safety and compliance with global pharmaceutical standards.
- Good Manufacturing Practice (GMP) – Ensuring high-quality pharmaceutical production
- ISO 9001 Certified – Complying with global quality management standards
- EU and FDA Compliance – Meeting stringent international regulatory requirements
- HACCP Standards – Guaranteeing feed and food safety protocols
Major Achievements
- Market leader in animal health, with over 70 years of industry expertise
- Expanded operations across 90+ countries, including strong growth in Thailand and Southeast Asia
- Invested over $300 million annually in R&D, developing cutting-edge veterinary pharmaceuticals
- Reduced antibiotic use in livestock by 20%, supporting global antimicrobial resistance (AMR) efforts
- Partnered with over 200,000 veterinarians and animal health professionals worldwide
With a strong foundation in research, sustainability, and market leadership, Elanco (Thailand) Ltd. continues to drive innovation in animal health, ensuring healthier animals, safer food production, and a more sustainable future for the global food chain.
